Axsome Therapeutics, Inc. (AXSM) NASDAQ
187.40
+1.44(+0.77%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
187.40
+1.44(+0.77%)
Currency In USD
| Market Cap | 9.09B |
| Enterprise Value | 9B |
| P/E Ratio | -51.8 |
| PEG Ratio | -1 |
| Price/Sales Ratio | 15.01 |
| Price/Book Ratio | 107.46 |
| Enterprise/Revenue | 14.89 |
| Enterprise/EBITDA | -57.09 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -0.29 |
| Operating Margin | -0.27 |
| Return On Assets | -0.27 |
| Return On Equity | -2.54 |
| Revenue | 638.5M |
| Revenue/Share | 12.61 |
| Gross Profit | 591.02M |
| EBITDA | -168.08M |
| Net Income | -183.17M |
| Diluted EPS | -3.68 |
| Total Cash | 322.93M |
| Total Cash/Share | 6.38 |
| Total Debt | 241.3M |
| Total Debt/Equity | 2.73 |
| Current Ratio | 1.55 |
| Book Value Per Share | 1.74 |
| 52-Week Change | 74.75 |
| 52-Week High | 193.49 |
| 52-Week Low | 96.09 |
| Moving Average 50 Days | 170.75 |
| Moving Average 200 Days | 145.86 |
| Average Volume | 600,531 |
| Shares Outstanding | 51.15M |
| % Held by Institutions | 75.24 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |